Fuller & Thaler Asset Management
ATRS

Fuller & Thaler Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-511,999
Closed -$2.04M – 573
2020
Q4 		$2.04M Sell
511,999
-27,100
-5% -$87.7K 0.02% 324
2020
Q3 		$1.46M Sell
539,099
-29,970
-5% -$82.9K 0.02% 322
2020
Q2 		$1.56M Sell
569,069
-14,590
-2% -$40.7K 0.02% 305
2020
Q1 		$1.38M Buy
583,659
+51,254
+10% +$174K 0.02% 293
2019
Q4 		$2.5M Buy
532,405
+1,700
+0.3% +$6.96K 0.03% 275
2019
Q3 		$1.77M Hold
530,705
– – 0.02% 299
2019
Q2 		$1.75M Sell
530,705
-2,700
-0.5% -$7.81K 0.02% 305
2019
Q1 		$1.62M Buy
533,405
+7,640
+1% +$24.8K 0.02% 305
2018
Q4 		$1.43M Buy
525,765
+8,465
+2% +$27.9K 0.02% 305
2018
Q3 		$1.74M Hold
517,300
– – 0.02% 314
2018
Q2 		$1.33M Hold
517,300
– – 0.01% 318
2018
Q1 		$1.14M Sell
517,300
-36,700
-7% -$82.6K 0.01% 314
2017
Q4 		$1.1M Sell
554,000
-176,600
-24% -$384K 0.01% 309
2017
Q3 		$2.37M Sell
730,600
-3,200
-0.4% -$9.87K 0.03% 231
2017
Q2 		$2.36M Sell
733,800
-2,600
-0.4% -$7.37K 0.03% 212
2017
Q1 		$2.09M Hold
736,400
– – 0.03% 208
2016
Q4 		$1.72M Hold
736,400
– – 0.03% 213
2016
Q3 		$1.24M Sell
736,400
-22,500
-3% -$27.6K 0.02% 229
2016
Q2 		$797K Buy
+758,900
New +$733K 0.01% 244

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fuller & Thaler Asset Management's ATRS Position: Q1 2021 in Review

Fuller & Thaler Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 511,999 shares — an estimated $2.04M sold.

Fuller & Thaler Asset Management first reported a position in ATRS in Q2 2016 and held it in 19 quarters. The position peaked at $2.5M in Q4 2019. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • Fuller & Thaler Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 511,999 Antares Pharma, Inc. shares in Q1 2021, an estimated $2.04M.
  • Fuller & Thaler Asset Management first reported a position in Antares Pharma, Inc. in Q2 2016 and held it in 19 quarters.
  • Fuller & Thaler Asset Management's Antares Pharma, Inc. position peaked at $2.5M in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2021, filed 13 May 2021.